Kukje Pharma Co Ltd (002720) — Cash Flow Quality Index
Kukje Pharma Co Ltd (002720) has a Cash Flow Quality Index of 2.61x as of September 2025. Operating cash flow of ₩4.99 Billion exceeds net income of ₩1.91 Billion, indicating high earnings quality where cash backs reported profits. Explore how much of Kukje Pharma Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kukje Pharma Co Ltd Cash Flow Quality Index (2011–2024)
Historical Cash Flow Quality Index for Kukje Pharma Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Kukje Pharma Co Ltd (002720) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Kukje Pharma Co Ltd (2011–2024)
Year-by-year earnings quality comparison for Kukje Pharma Co Ltd. For live market cap and the full company financial profile, see 002720 stock market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.76x | ₩3.94 Billion | ₩5.21 Billion | ▼ -58.6% |
| 2022 | 1.83x | ₩6.50 Billion | ₩3.56 Billion | ▼ -21.0% |
| 2020 | 2.32x | ₩5.10 Billion | ₩2.20 Billion | ▼ -61.7% |
| 2018 | 6.04x | ₩13.25 Billion | ₩2.19 Billion | ▲ +739.6% |
| 2017 | 0.72x | ₩786.10 Million | ₩1.09 Billion | ▼ -96.5% |
| 2016 | 20.82x | ₩16.10 Billion | ₩773.06 Million | ▲ +857.6% |
| 2013 | -2.75x | ₩-4.60 Billion | ₩1.67 Billion | ▼ -114.7% |
| 2011 | 18.74x | ₩17.39 Billion | ₩927.81 Million | — |